Endocrine neoplasia
Gene: PTEN
After NHS Genomic Medicine Service consideration, the rating of this gene has not been changed and remains Amber.Created: 2 Feb 2023, noon | Last Modified: 2 Feb 2023, noon
Panel Version: 2.2
This gene was proposed to be added to this panel with Green status by Soo-Mi Park (East Anglian Medical Genetics Service). No further evidence was provided.
This gene has been given an Amber rating and will reviewed by GMS before Green status is given.
Sources: Expert listCreated: 11 Feb 2021, 11:28 a.m. | Last Modified: 11 Feb 2021, 11:31 a.m.
Panel Version: 1.14
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
Tag Q2_21_rating was removed from gene: PTEN. Tag Q2_21_phenotype was removed from gene: PTEN. Tag Q2_21_expert_review was removed from gene: PTEN. Tag Q2_21_NHS_review was removed from gene: PTEN.
Tag Q2_21_expert_review tag was added to gene: PTEN.
Tag Q2_21_rating tag was added to gene: PTEN. Tag Q2_21_NHS_review tag was added to gene: PTEN.
Gene: pten has been classified as Amber List (Moderate Evidence).
gene: PTEN was added gene: PTEN was added to Endocrine neoplasms. Sources: Expert list Q2_21_phenotype tags were added to gene: PTEN. Mode of inheritance for gene: PTEN was set to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown Review for gene: PTEN was set to AMBER